📰 Grant Date News
Page 17 - Grant Date News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Grant Date. Real-time updates on events, politics, business and more.
September 19, 2022
Investegate announcements from Atlantic Lithium Ltd, Corporate Update - Issue of Equity / PCA Dealings
September 13, 2022
SURREY, BC / ACCESSWIRE / September 13, 2022 / Condor Gold plc, (AIM:CNR; TSX:COG) announces that on 13 September 2022 (the "Grant Date") it granted 4,200,000 share options, representing 2.65% of the issued
September 2, 2022
02.09.2022 - Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company developing STAR-0215 for the treatment of hereditary angioedema and focused on life-changing therapies for rare and niche allergic and immunological diseases, granted stock options ...
September 1, 2022
31.08.2022 - CAMBRIDGE, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) - Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on August 31, 2022 that were previously approved by the Compensation ...
August 26, 2022
Toronto, Ontario--(Newsfile Corp. - August 26, 2022) - Deveron Corp. (TSXV: FARM) ("Deveron" or the "Company"), a leading agriculture data company in North America, is pleased to announce it has granted
August 22, 2022
/PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that an authorized subcommittee of the Compensation Committee of its Board of Directors...
August 10, 2022
Appoints Timothy E. Morris, a veteran biotech executive with over 35 years of experience in executive and financial leadership, to Board of DirectorsNames...
August 1, 2022
/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...
August 1, 2022
/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...
July 29, 2022
CAMBRIDGE, Mass., July 29, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases,...